BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home » Authors » Ned Stafford

Ned Stafford

Articles

ARTICLES

Novacyt launches two IVD products in EU, cuts 2018 revenue expectations

Dec. 28, 2018
By Ned Stafford

Boston Sci triggers $325M option to acquire full ownership of Millipede

Dec. 28, 2018
By Ned Stafford
HAMBURG, Germany – Boston Scientific Corp. exercised its $325 million option to acquire remaining shares and full ownership of Millipede Inc. upon Millipede's recent successful completion of a first-in-human clinical study of its system treatment of severe mitral regurgitation. Boston Scientific had already invested $90 million in the privately held company in January.
Read More

Digital behavior change firm Changing Health gets £3 million in fresh funds

Dec. 27, 2018
By Ned Stafford

Global team develops fast, portable platform for diagnosing Ebola

Dec. 24, 2018
By Ned Stafford

Allergan suspends EU breast implant sales, share prices plunge on news

Dec. 20, 2018
By Ned Stafford
HAMBURG, Germany – Dublin-based pharmaceutical and medical device firm Allergan plc suspended sales in Europe of its textured breast implants and tissue expanders and is withdrawing any remaining supplies from the market following a compulsory recall request from France's National Agency for the Safety of Medicines and Health Products (ANSM).
Read More

M-health apps for drug use hold potential, but still in infancy, says European study

Dec. 19, 2018
By Ned Stafford

Mobidiag establishes JV in China with Autobio Diagnostics

Dec. 18, 2018
By Ned Stafford

Biomarker test distinguishes epileptic from psychogenic nonepileptic seizures

Dec. 11, 2018
By Ned Stafford

Fresenius group shares plunge after company issues bleak profit warning

Dec. 10, 2018
By Ned Stafford
HAMBURG, Germany – Shares of German health care group Fresenius SE & Co. KGaA plunged Dec. 7 on the Frankfurt Stock Exchange after the company issued a profit warning, saying that it expects stagnant profits in 2019 and believes its group profit targets for 2020 will not be met.
Read More

Scibase, Swiss institute team up to develop new skin diagnostics tool

Dec. 7, 2018
By Ned Stafford
View All Articles by Ned Stafford

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing